Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression

Psychiatry Research - Neuroimaging

Volumn 212, Issue 3, 2013, Pages 216-222

  Ho, Pei Shen ^a,b   Ho, Kellen Kai Jen ^a,b   Huang, Wen Sheng ^a   Yen, Che Hung ^a   Shih, Mei Chen ^a   Shen, Lie Hang ^c   Ma, Kuo Hsing ^d   Huang, San Yuan ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Beitou Armed Forces Hospital   (Taiwan)

^c INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

123I ADAM; Major depression; Serotonin transporter; SLC6A4; SPECT

Indexed keywords

IODINE 123;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR DEPRESSION; MALE; MESENCEPHALON; PONS; PRIORITY JOURNAL; SEROTONIN TRANSPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLC6A4 GENE; THALAMUS;

ADULT; ALLELES; BRAIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84878126801     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.04.005     Document Type: Article

References (46)

1. Belmaker R.H., Agam G. Major depressive disorder. New England Journal of Medicine 2008, 358:55-68.
2. Brust P., Hesse S., Muller U., Szabo Z. Neuroimaging of the serotonin trasporter-possibilities and pitfalls. Current Psychiatry Reviews 2006, 2:111-149.
3. Cannon D.M., Ichise M., Rollis D., Klaver J.M., Gandhi S.K., Charney D.S., Manji H.K., Drevets W.C. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biological Psychiatry 2007, 62:870-877.
4. 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers. Journal of Nuclear Medicine 2005, 46:1301-1309.
5. 123I-ADAM SPECT study. Psychopharmacology (Berl) 2006, 189:145-153.
6. Chalon S., Bronquard C., Vercouillie J., Kodas E., Garreau L., Bodard S., Emond P., Besnard J.C., Guilloteau D. ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models. Synapse 2004, 52:136-142.
7. Chou Y.H., Yang B.H., Chung M.Y., Chen S.P., Su T.P., Chen C.C., Wang S.J. Imaging the serotonin transporter using (123)I-ADAM in the human brain. Psychiatry Research: Neuroimaging 2009, 172:38-43.
8. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978, 35:837-844.
9. Erritzoe D., Frokjaer V.G., Haahr M.T., Kalbitzer J., Svarer C., Holst K.K., Hansen D.L., Jernigan T.L., Lehel S., Knudsen G.M. Cerebral serotonin transporter binding is inversely related to body mass index. Neuroimage 2010, 52:284-289.
10. Haleem D.J., Batool F. Regionally specific effects of diazepam on brain serotonin metabolism in rats: sustained effects following repeated administration. Life Sciences 1996, 59:PL239-PL246.
11. Heils A., Mossner R., Lesch K.P. The human serotonin transporter gene polymorphism-basic research and clinical implications. Journal of Neural Transmission 1997, 104:1005-1014.
12. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., Linnoila M., Weinberger D.R. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biological Psychiatry 2000, 47:643-649.
13. Heinz A., Jones D.W., Zajicek K., Gorey J.G., Juckel G., Higley J.D., Weinberger D.R. Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates. Journal of Neural Transmission 2004, (Suppl.):29-38.
14. 123I]-ADAM. Journal of Neural Transmission 2006, 113:659-670.
15. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics 2006, 78:815-826.
16. 123I-ADAM brain SPECT in healthy non-human primates. Nuclear Medicine Communications 2004, 25:515-519.
17. Joensuu M., Tolmunen T., Saarinen P.I., Tiihonen J., Kuikka J., Ahola P., Vanninen R., Lehtonen J. Reduced midbrain serotonin transporter availability in drug-naive patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Research: Neuroimaging 2007, 154:125-131.
18. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry 2011, 68:444-454.
19. Kish S.J., Furukawa Y., Chang L.J., Tong J., Ginovart N., Wilson A., Houle S., Meyer J.H. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?. Nuclear Medicine and Biology 2005, 32:123-128.
20. Kobiella A., Reimold M., Ulshofer D.E., Ikonomidou V.N., Vollmert C., Vollstadt-Klein S., Rietschel M., Reischl G., Heinz A., Smolka M.N. How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure. Translational Psychiatry 2011, 1:e37.
21. Kremer I., Bachner-Melman R., Reshef A., Broude L., Nemanov L., Gritsenko I., Heresco-Levy U., Elizur Y., Ebstein R.P. Association of the serotonin transporter gene with smoking behavior. American Journal of Psychiatry 2005, 162:924-930.
22. 123I]nor-beta-CIT in atypical depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006, 30:1251-1255.
23. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
24. Lundquist P., Wilking H., Hoglund A.U., Sandell J., Bergstrom M., Hartvig P., Langstrom B. Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies. Nuclear Medicine and Biology 2005, 32:129-136.
25. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biological Psychiatry 1998, 44:1090-1098.
26. Meyer J.H. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. Journal of Psychiatry and Neuroscience 2007, 32:86-102.
27. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., Goulding V., Kennedy J., Wilson A.A. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry 2004, 61:1271-1279.
28. Meyer J.H., Wilson A.A., Ginovart N., Goulding V., Hussey D., Hood K., Houle S. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. American Journal of Psychiatry 2001, 158:1843-1849.
29. Murthy N.V., Selvaraj S., Cowen P.J., Bhagwagar Z., Riedel W.J., Peers P., Kennedy J.L., Sahakian B.J., Laruelle M.A., Rabiner E.A., Grasby P.M. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. Neuroimage 2010, 52:50-54.
30. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. Journal of Nuclear Medicine 2005, 46:973-977.
31. Newberg A.B., Plossl K., Mozley P.D., Stubbs J.B., Wintering N., Udeshi M., Alavi A., Kauppinen T., Kung H.F. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent. Journal of Nuclear Medicine 2004, 45:834-841.
32. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X., Goldman D., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. American Journal of Psychiatry 2006, 163:48-51.
33. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry 2006, 163:52-58.
34. 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. Journal of Nuclear Medicine 2000, 41:36-44.
35. Praschak-Rieder N., Kennedy J., Wilson A.A., Hussey D., Boovariwala A., Willeit M., Ginovart N., Tharmalingam S., Masellis M., Houle S., Meyer J.H. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biological Psychiatry 2007, 62:327-331.
36. Rausch J.L., Fefferman M., Ladisich-Rogers D.G., Menard M. Effect of nicotine on human blood platelet serotonin uptake and efflux. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1989, 13:907-916.
37. Reimold M., Batra A., Knobel A., Smolka M.N., Zimmer A., Mann K., Solbach C., Reischl G., Schwarzler F., Grunder G., Machulla H.J., Bares R., Heinz A. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Molecular Psychiatry 2008, 13(606-613):557.
38. Reimold M., Smolka M.N., Schumann G., Zimmer A., Wrase J., Mann K., Hu X.Z., Goldman D., Reischl G., Solbach C., Machulla H.J., Bares R., Heinz A. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. Journal of Neural Transmission 2007, 114:635-639.
39. Ruhe H.G., Booij J., Reitsma J.B., Schene A.H. Serotonin transporter binding with [(123)I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. European Journal of Nuclear Medicine and Molecular Imaging 2009, 841-849.
40. Selvaraj S., Murthy N.V., Bhagwagar Z., Bose S.K., Hinz R., Grasby P.M., Cowen P.J. Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB. Psychopharmacology (Berl) 2011, 213:555-562.
41. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 2001, 41:275-284.
42. Staley J.K., Sanacora G., Tamagnan G., Maciejewski P.K., Malison R.T., Berman R.M., Vythilingam M., Kugaya A., Baldwin R.M., Seibyl J.P., Charney D., Innis R.B. Sex differences in diencephalon serotonin transporter availability in major depression. Biological Psychiatry 2006, 59:40-47.
43. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. Journal of Psychiatric Research 2003, 37:357-373.
44. 123I]beta-CIT SPECT in relation to serotonin transporter genotype. American Journal of Psychiatry 2004, 161:525-531.
45. Wu X., Castren E. Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells. Biological Psychiatry 2009, 66:5-8.
46. Zhang J.L., Yang J.F., Chan P. No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese. Neuroscience Letters 2009, 455:155-158.